Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS).
- Disclosed ownership: 3.5%.
- Date of event: 31 Dec 2024.
INTEGRATED CORE STRATEGIES (US) LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- ATXS
- Shares outstanding
- 56,985,800 shares
- Disclosed Ownership
- 1,994,503 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 28 Jan 2025, 16:00:18 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 18 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 3.5% ownership in Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Jan 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 3.5% | 1,960,135 | 0 | 1,960,135 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 3.5% | 1,994,503 | 0 | 1,994,503 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 3.5% | 1,994,503 | 0 | 1,994,503 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 3.5% | 1,994,503 | 0 | 1,994,503 | /s/ Israel A. Englander | Israel A. Englander |